Lowell Farms Welcomes Jeff Monat to Board of Directors
California-based cannabis leader adds veteran finance executive and investor to leadership teamSALINAS, Calif., Jan. 14, 2022 (GLOBE NEWSWIRE) -- Lowell...
News
Founder and Executive Chairman of Emergent BioSolutions Announces Retirement
Fuad El-Hibri to Retire After More Than 20 YearsGAITHERSBURG, Md., Jan. 14, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:...
AirPhysio For COPD Symptoms – Treatment And Reviews YouTube Channel Launched
Life Wellness Healthcare has launched a YouTube channel discussing topics related to respiratory health, COPD, and reviews for the AirPhysio...
Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux
Daix (France), Long Island City (New York), January 14, 2022 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical...
Corvus Pharmaceuticals Announces Partner Angel Pharmaceuticals Initiated Phase 1/1b Clinical Trial of ITK Inhibitor CPI-818 in China
BURLINGAME, Calif., Jan. 13, 2022 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Corvus or the Company) (NASDAQ: CRVS), a clinical-stage biopharmaceutical...
Surgalign Holdings, Inc. to Participate at the Sidoti Virtual Small Cap Conference
DEERFIELD, Ill., Jan. 13, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (NASDAQ: SRGA), a global medical technology company focused on...
Celsion Corporation Announces Pricing of $30 Million Registered Direct Offerings of Convertible Redeemable Preferred Stock
LAWRENCEVILLE, N.J., Jan. 13, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), a clinical-stage development company focused on DNA-based immunotherapy...
Vaccitech to Host Virtual KOL Event on VTP-300, a Potential Functional Cure for Chronic Hepatitis B (CHB) Infection, and the Broader CHB Therapeutics Landscape
Live webcast will be at 8:30 a.m. EST on January 25OXFORD, United Kingdom, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Vaccitech...
InteliSwab® COVID-19 Rapid Tests Detect Omicron at Same Level as Other Variants
InteliSwab test With less than one minute of “hands-on time,” the InteliSwab test is as simple as “Swab, Swirl, and...
Galapagos creates new subscription right plan
Mechelen, Belgium; 13 January 2022, 22.01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) announced today that its supervisory...
REPEAT — Revelation Biosciences Inc. Announces Data Demonstrating REVTx-99 In Vitro Anti-Viral Activity Against SARS-CoV-2; Commencement of Trading as a Public Company
-A greater than 50% reduction in SARS-CoV-2 Delta viral load was observed- -REVTx-99 was tested prior to infection in multiple...
Doctors Call for Rethinking COVID Strategy
TUCSON, Ariz., Jan. 13, 2022 (GLOBE NEWSWIRE) -- In response to calls for doubling down on costly failed public health...
Veranome Biosystems and Cold Spring Harbor Laboratory Enter Collaboration and Licensing Agreement to Develop Advanced In-Situ Sequencing Technologies
Veranome expands its spatial omics intellectual property portfolio into unbiased in-situ sequencing to address a broader set of applications with...
Safe group announces consolidated annual sales of €4.6M, up 23%
A return to growth in direct sales of Safe OrthopaedicsSafe Medical annual sales up 50% Cash position of €0.9M and...
Bluejay Diagnostics, Inc. Completes 90 Subjects in Multicenter Clinical Study Addressing Rapid IL-6 Test for COVID-19 Patients in Critical Care
This Study performs unique rapid on-site measurement using patient whole blood and positions Company to move forward with multiple initiativesACTON,...
myAir Smart-Food Leverages AI for Stress Relief Through Functional, Personalized Nutrition
myAir Launches AI System For Natural Stress Management myAir Insights combines functional, plant-based nutrition with data-driven technology to create a...
AI Therapeutics Announces Initiation of a Phase II Clinical Trial of AIT-101 for Treatment of ALS
Promising New Approach for a Fatal Neurological DisorderGUILFORD, Conn., Jan. 13, 2022 (GLOBE NEWSWIRE) -- AI Therapeutics, Inc., a clinical-stage...
Sorrento Therapeutics Mexico Wins Tender to Sell COVISTIX Tests to Mexico City Government
SAN DIEGO, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) announced today Sorrento Therapeutics Mexico (“Sorrento...
Captor Therapeutics Presents Compelling In Vivo Proof-of-Concept Data from CT-01 Program in Hepatocellular Carcinoma
Data confirm strong anticancer activity of two lead compounds in CT-01 programResults support advancement of CT-01 compounds towards IND expected...
Rhythm Pharmaceuticals Announces First Patients Dosed in DAYBREAK and Weekly Trials Evaluating Setmelanotide for Rare Genetic Diseases of Obesity
-- DAYBREAK is the most comprehensive Phase 2 trial ever initiated in rare genetic diseases of obesity ---- DAYBREAK is...
